欧林生物
(688319)
| 流通市值：111.04亿 | | | 总市值：111.19亿 |
| 流通股本：4.05亿 | | | 总股本：4.06亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 506,920,470.94 | 305,849,689.82 | 87,490,281.98 | 588,858,464.45 |
| 营业收入 | 506,920,470.94 | 305,849,689.82 | 87,490,281.98 | 588,858,464.45 |
| 二、营业总成本 | 440,264,661.39 | 267,455,854.27 | 103,562,135.21 | 569,996,827.89 |
| 营业成本 | 34,993,613.76 | 20,889,102.06 | 5,748,186.46 | 32,707,434.85 |
| 税金及附加 | 3,305,954.34 | 2,477,746.03 | 512,277.03 | 3,716,416.72 |
| 销售费用 | 246,180,116.82 | 145,278,282.45 | 41,886,928.76 | 302,899,962.16 |
| 管理费用 | 50,362,440.62 | 32,902,561.01 | 22,743,811.47 | 86,424,382.85 |
| 研发费用 | 94,881,270.69 | 58,777,526.47 | 29,123,911.81 | 134,233,724.19 |
| 财务费用 | 10,541,265.16 | 7,130,636.25 | 3,547,019.68 | 10,014,907.12 |
| 其中:利息费用 | 10,815,243.51 | 7,455,488.08 | 3,719,578.74 | 14,283,986.99 |
| 其中:利息收入 | 551,837.97 | 425,415.39 | 229,609.01 | 4,508,119.26 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 259,436.3 | 150,511.64 | 70,592.05 | 855,559.79 |
| 资产处置收益 | 8,707.5 | 8,707.5 | - | -30,988.3 |
| 资产减值损失(新) | -3,558,183.17 | 491,601.37 | 1,271,436.02 | 2,936,350.79 |
| 信用减值损失(新) | -16,136,383.66 | -31,837,465.84 | 3,388,796.25 | -10,375,765.79 |
| 其他收益 | 8,376,168.21 | 7,484,305.7 | 4,297,791.76 | 9,063,439.56 |
| 四、营业利润 | 55,605,554.73 | 14,691,495.92 | -7,043,237.15 | 21,310,232.61 |
| 加:营业外收入 | 259,679.77 | 5,958.53 | 1,703.81 | 1,140,439.08 |
| 减:营业外支出 | 114,669.24 | 14,669.24 | - | 146,971.33 |
| 五、利润总额 | 55,750,565.26 | 14,682,785.21 | -7,041,533.34 | 22,303,700.36 |
| 减:所得税费用 | 8,602,256.82 | 1,452,994.79 | - | 6,583,013.04 |
| 六、净利润 | 47,148,308.44 | 13,229,790.42 | -7,041,533.34 | 15,720,687.32 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 47,148,308.44 | 13,229,790.42 | -7,041,533.34 | 15,720,687.32 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 47,479,767.98 | 13,196,891.47 | -7,073,911.78 | 20,757,584.86 |
| 少数股东损益 | -331,459.54 | 32,898.95 | 32,378.44 | -5,036,897.54 |
| 扣除非经常损益后的净利润 | 40,042,630.48 | 7,723,574.58 | -11,022,704.59 | 11,180,820.89 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 0.03 | -0.02 | 0.05 |
| (二)稀释每股收益 | 0.12 | 0.03 | -0.02 | 0.05 |
| 九、综合收益总额 | 47,148,308.44 | 13,229,790.42 | -7,041,533.34 | 15,720,687.32 |
| 归属于母公司股东的综合收益总额 | 47,479,767.98 | 13,196,891.47 | -7,073,911.78 | 20,757,584.86 |
| 归属于少数股东的综合收益总额 | -331,459.54 | 32,898.95 | 32,378.44 | -5,036,897.54 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-26 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |